Literature DB >> 33471314

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection.

Archana Khan1, Hiren Panwala2, Divya Ramadoss3, Raju Khubchandani3.   

Abstract

Entities:  

Year:  2021        PMID: 33471314      PMCID: PMC7815970          DOI: 10.1007/s12098-020-03656-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
To the Editor: SARS-CoV-2 causes multiorgan damage. There is an increasing evidence of extra-pulmonary involvement including the nerve cells and eye [1]. MOG is a glycoprotein located on the myelin surface and optic neuritis is the commonest presentation of myelin oligodendrocyte glycoprotein antibody disease (MOG-AD) seen in 54%–61% of patients [1]. There are two reports of SARS CoV-2 associated MOG-AD causing optic neuritis in a 15 and 26 y old [2, 3]. A 11-year-old boy presented with redness and ophthalmodynia in both eyes four days after a brief febrile illness. Two weeks later, there was overnight loss of vision in the right eye without any systemic or neurologic complaints. There was bilateral conjunctival congestion with painful movement of eye. Right eye findings showed normal perception and projection of light, sluggishly reactive pupils, vision of < N/36 and disc edema of Grade 3 relative afferent pupillary defect. Left eye vision was 6/9. Hemogram, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were normal. SARS-CoV-2 nasopharyngeal swab was positive by CBNAAT. Serum anti-SARS-CoV-2 immunoglobulin (IgG) antibodies were reactive 20.8 (Normal range < 1.0). Serum MOG antibody was positive. Aquaporin-4 antibody was not detected. Cerebrospinal fluid (CSF) showed mild lymphocytic pleocytosis (55/mL normal - < 5 cells/mL) while proteins and glucose were normal. Oligoclonal bands, MOG-IgG and cultures were negative. CSF- SARS-CoV-2 ribonucleic acid (RNA) polymerase chain reaction (PCR) was not done. Magnetic resonance imaging (MRI) findings showed bilateral asymmetrical optic neuritis, involving intraorbital and intracanalicular portion on the right and intraorbital portion on the left. Altered signal intensities were segmental and diffuse in the right intraorbital optic nerve and patchy in the left intraorbital optic nerve with enhancement of the optic nerve sheath in the right orbit. The chiasmatic, retrochiasmatic portion, optic tracts, rest of brain and spine were normal. These findings were consistent with MOG antibody associated disease [4]. Response to pulse methylprednisolone was dramatic. Oral steroids were continued and tapered over 12 wk. Right eye vision improved to 6/9 and left eye to 6/6 by day 10. We thus concluded a diagnosis of MOG-AD-associated bilateral optic neuritis adding to the small body of evidence of SARS-CoV-2 associated MOG-AD as yet another neurological feature of this deadly virus.
  10 in total

1.  Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19: a case report and a review of the literature.

Authors:  Mark A Colantonio; Divine C Nwafor; Shruti Jaiswal; Ashish K Shrestha; Mahmoud Elkhooly; Steven Rollins; Sijin Wen; Shitiz Sriwastava
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2022-05-31

2.  Myelin-oligodendrocyte glycoprotein antibody-associated optic neuritis following SARS-CoV-2 pneumonia: A case report.

Authors:  Witoon Mitarnun; Theerawat Naksanguan; Nutchaya Laoharattanahirun; Patarasaya Roekrat; Suphakarn Kimavaha; Warut Kajornrith
Journal:  Neurol Clin Neurosci       Date:  2022-03-26

3.  Post COVID-19 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

Authors:  Daniela Ximena Rojas-Correa; José Alberto Reche-Sainz; Alfredo Insausti-García; Cristina Calleja-García; Manuel Ferro-Osuna
Journal:  Neuroophthalmology       Date:  2021-05-24

4.  Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review.

Authors:  Buravej Assavapongpaiboon; Supanut Apinyawasisuk; Supharat Jariyakosol
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-17

Review 5.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

6.  Para and Post-COVID-19 CNS Acute Demyelinating Disorders in Children: A Case Series on Expanding the Spectrum of Clinical and Radiological Characteristics.

Authors:  Abdulhafeez M Khair; Rahul Nikam; Sumair Husain; Melanie Ortiz; Gurcharanjeet Kaur
Journal:  Cureus       Date:  2022-03-22

Review 7.  SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review.

Authors:  Toshihiro Ide; Takeru Kawanami; Makoto Eriguchi; Hideo Hara
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

8.  SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.

Authors:  Magnus Johnsson; Fredrik Asztely; Susanne Hejnebo; Markus Axelsson; Clas Malmeström; Torbjörn Olausson; Jan Lycke
Journal:  Ann Clin Transl Neurol       Date:  2022-06-17       Impact factor: 5.430

9.  Childhood Multisystem Inflammatory Syndrome With Prominent Neurological Involvement.

Authors:  Gül Demet Kaya Özçora; Ferhan Çetindağ; Murat Doğan; Murat Baştemir
Journal:  Pediatr Neurol       Date:  2022-08-04       Impact factor: 4.210

10.  COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Authors:  Itay Lotan; Shuhei Nishiyama; Giovanna S Manzano; Melissa Lydston; Michael Levy
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.